EGX: CPCI Statistics

Total Valuation

Kahira Pharmaceuticals & Chemical Industries Company has a market cap or net worth of EGP 1.51 billion. The enterprise value is 1.56 billion.

Market Cap	1.51B
Enterprise Value	1.56B

Important Dates

The next estimated earnings date is Thursday, February 13, 2025.

Earnings Date	Feb 13, 2025
Ex-Dividend Date	Dec 24, 2024

Share Statistics

Kahira Pharmaceuticals & Chemical Industries Company has 14.93 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class	n/a
Shares Outstanding	14.93M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	-0.43%
Owned by Insiders (%)	0.01%
Owned by Institutions (%)	n/a
Float	2.72M

Valuation Ratios

The trailing PE ratio is 5.78.

PE Ratio	5.78
Forward PE	n/a
PS Ratio	1.04
PB Ratio	1.66
P/TBV Ratio	1.67
P/FCF Ratio	78.39
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 4.82, with an EV/FCF ratio of 80.89.

EV / Earnings	5.96
EV / Sales	1.07
EV / EBITDA	4.82
EV / EBIT	5.15
EV / FCF	80.89

Financial Position

The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.26.

Current Ratio	2.33
Quick Ratio	1.50
Debt / Equity	0.26
Debt / EBITDA	0.72
Debt / FCF	12.07
Interest Coverage	16.04

Financial Efficiency

Return on equity (ROE) is 31.65% and return on invested capital (ROIC) is 17.86%.

Return on Equity (ROE)	31.65%
Return on Assets (ROA)	13.15%
Return on Capital (ROIC)	17.86%
Revenue Per Employee	768,790
Profits Per Employee	138,759
Employee Count	1,883
Asset Turnover	1.01
Inventory Turnover	2.30

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +60.94% in the last 52 weeks. The beta is 0.04, so Kahira Pharmaceuticals & Chemical Industries Company's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	+60.94%
50-Day Moving Average	105.05
200-Day Moving Average	82.91
Relative Strength Index (RSI)	50.65
Average Volume (20 Days)	5,186

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Kahira Pharmaceuticals & Chemical Industries Company had revenue of EGP 1.45 billion and earned 261.28 million in profits. Earnings per share was 17.47.

Revenue	1.45B
Gross Profit	537.64M
Operating Income	302.35M
Pretax Income	334.85M
Net Income	261.28M
EBITDA	318.80M
EBIT	302.35M
Earnings Per Share (EPS)	17.47

Full Income Statement

Balance Sheet

The company has 184.19 million in cash and 232.26 million in debt, giving a net cash position of -48.08 million or -3.22 per share.

Cash & Cash Equivalents	184.19M
Total Debt	232.26M
Net Cash	-48.08M
Net Cash Per Share	-3.22
Equity (Book Value)	905.29M
Book Value Per Share	60.88
Working Capital	625.50M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 284.67 million and capital expenditures -265.43 million, giving a free cash flow of 19.24 million.

Operating Cash Flow	284.67M
Capital Expenditures	-265.43M
Free Cash Flow	19.24M
FCF Per Share	1.29

Full Cash Flow Statement

Margins

Gross margin is 37.14%, with operating and profit margins of 20.89% and 18.05%.

Gross Margin	37.14%
Operating Margin	20.89%
Pretax Margin	23.13%
Profit Margin	18.05%
EBITDA Margin	22.02%
EBIT Margin	20.89%
FCF Margin	1.33%

Dividends & Yields

This stock pays an annual dividend of 12.83, which amounts to a dividend yield of 12.71%.

Dividend Per Share	12.83
Dividend Yield	12.71%
Dividend Growth (YoY)	156.60%
Years of Dividend Growth	1
Payout Ratio	32.73%
Buyback Yield	-0.13%
Shareholder Yield	12.58%
Earnings Yield	17.33%
FCF Yield	1.28%

Dividend Details

Stock Splits

The last stock split was on September 10, 2020. It was a forward split with a ratio of 1.25.

Last Split Date	Sep 10, 2020
Split Type	Forward
Split Ratio	1.25

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a